In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 15944-34-0, name is 7-Chloro-1,8-naphthyridin-2-ol, introducing its new discovery. Safety of 7-Chloro-1,8-naphthyridin-2-ol
WARNER-LAMBERT COMPANY LLC
Compounds of formula 1 (1) are disclosed, wherein G is as shown in formula (i): (i). A of formula 1 is-(CH2)nCO-, wherein n is 4 or 5, and one or two of the carbon atoms of A can be substituted as described in the specification. D, Z, Q, X, Y, K, J, R 1, R4 through R7, and R9 through R11 of formulae 1 and (i) are defined in the specification. Also provided are descriptions of processes for preparing compounds of formula 1, intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 15944-34-0, and how the biochemistry of the body works.Safety of 7-Chloro-1,8-naphthyridin-2-ol
Reference£º
1,512-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N506 – PubChem